Novartis India Limited reported standalone unaudited earnings results for the fourth quarter and audited earnings results for the full year ended of March 31, 2017. For the quarter, the company reported revenue from operations of INR 1,454.9 million compared to INR 1,662.1 million a year ago. Total income was INR 1,603.0 million against INR 1,871.9 million a year ago. Profit before tax from continuing operations was INR 71.6 million against INR 326.0 million a year ago. Profit from continuing operations was INR 29.1 million or INR 1.03 per basic and diluted share against INR 228.3 million or INR 7.14 per basic and diluted share a year ago. Profit for the period was INR 29.1 million or INR 1.03 per basic and diluted share against INR 228.3 million or INR 7.14 per basic and diluted share a year ago. For the year, the company reported revenue from operations of INR 6,562.3 million compared to INR 6,899.0 million a year ago. Total income was INR 7,263.8 million against INR 7,707.8 million a year ago. Profit before tax from continuing operations was INR 917.3 million against INR 1,113.7 million a year ago. Profit from continuing operations was INR 572.2 million or INR 19.10 per basic and diluted share against INR 724.9 million or INR 22.68 per basic and diluted share a year ago. Profit for the period was INR 572.2 million or INR 19.10 per basic and diluted share against INR 1,982.9 million or INR 62.04 per basic and diluted share a year ago.